Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probiotics for Prevention of Irinotecan-Induced Diarrhea
NCT02819960Phase 3Completed
- Sponsor
- S&D Pharma
- Start
- Mar 2016
- Primary completion
- Aug 2022
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 3 trial of bifidobacterium animalis subsp. lactis + lacticaseibacillus rhamnosus in diarrhea, sponsored by S&D Pharma. Started Mar 2016; status: completed.
02
Drugs
bifidobacterium animalis subsp. lactis + lacticaseibacillus rhamnosus
03
Conditions
diarrhea
Beyond the preview
Go deeper on NCT02819960.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02819960.